CRISPR Medicine News

About CRISPR Medicine News

Welcome to CRISPR Medicine News.
We are a global independent online media writing about gene therapy and genome editing.
Read more.

CLINICAL TRIALS
Beta-Thalassemia, BT, (NCT06024876)
Sponsors:
CorrectSequence Therapeutics Co., Ltd
Indicator
IND Enabling
Phase I
Phase II
Phase III
Transfusion-dependent Beta-Thalassemia, TDT, (NCT06065189)
Sponsors:
Children's Hospital of Fudan University
Indicator
IND Enabling
Phase I
Phase II
Phase III
Transfusion-dependent Beta-Thalassemia, TDT, (NCT06291961)
Sponsors:
CorrectSequence Therapeutics Co., Ltd
Indicator
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
Harvard Medical School (@HMS)

Genome Engineering Seminar Series (GESS)

Read more...Harvard Medical School (@HMS)
Join WDC Chat Community
WDC Chat Community
CRISPR Medicine News
close
Search CRISPR Medicine